Hebei Yuxing Bio-Engineering Co. Ltd

Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America.^[1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination."^[2]

References

^ Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
^ "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Hebei_Yuxing_Bio-Engineering_Co._Ltd
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

['The_Rooms_Had_Never_Been_Cleaned':_Two_New_FDA_Warning_Letters_for_Chinese_Manufacturers-1] Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.

[Hebei_Yuxing_Bio-Engineering_Co_Ltd_9/6/16-2] "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.

[1]

[2]